Y-mAbs Therapeutics
YMAB
#6804
Rank
NZ$0.79 B
Marketcap
$17.83
Share price
3.07%
Change (1 day)
98.29%
Change (1 year)

Market capitalization of Y-mAbs Therapeutics (YMAB)

Market cap: NZ$0.79 Billion

As of November 2024 Y-mAbs Therapeutics has a market cap of NZ$0.79 Billion. This makes Y-mAbs Therapeutics the world's 6804th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Y-mAbs Therapeutics from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$0.79 B69.79%
2023NZ$0.47 B40.16%
2022NZ$0.33 B-67.59%
2021NZ$1.03 B-62.74%
2020NZ$2.77 B50.8%
2019NZ$1.84 B77.79%
2018NZ$1.03 B

End of Day market cap according to different sources

On Nov 23rd, 2024 the market cap of Y-mAbs Therapeutics was reported to be:

NZ$0.79 Billion
by Nasdaq info icon info icon
NZ$0.79 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$1.15 B 45.14%๐Ÿ‡บ๐Ÿ‡ธ USA